June 2018

Physiomics is pleased to announce that following feedback from clients and shareholders it has today updated its website at http://www.physiomics-plc.com/.  In its recent placing announcement of the 23 May 2018, the Company stated its intention to improve its marketing approach, and the launch of the new site is a small but important step towards executing this goal.  Features of the upgraded site include: Fresher, cleaner...

Read More

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it has completed a placing, conditional only on Admission, to raise £525,000.00 (gross) from the issue of 13,125,000 new ordinary shares of 0.4p each ("Ordinary Shares") at a price of 4.0p per share, through Hybridan LLP (the "Placing"). Application...

Read More

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is delighted to announce that it has been awarded a contract by a new UK based biotech client.  The value of the contract is £48k and it is expected to complete in this calendar year. Click here to read in full....

Read More

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it will attend BioTrinity 2018.  BioTrinity is one of Europe’s leading biopartnering and investment conferences, to be held on 23-25 April at the Novotel London West. Click here to read more....

Read More

Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, is pleased to announce that it is participating in the AACR Annual Meeting 2018, taking place at the McCormick Place Convention Center, Chicago, Illinois, on 14-18 April 2018.  Dr Hitesh Mistry will present a poster based on the Company’s recently completed personalised medicine project. Click here to...

Read More